TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $745,446 | -52.6% | 148,200 | -17.5% | 0.34% | -52.0% |
| Q2 2023 | $1,572,113 | -9.6% | 179,670 | +22.3% | 0.72% | -49.2% |
| Q1 2023 | $1,738,751 | +120.8% | 146,854 | +89.9% | 1.42% | +203.2% |
| Q4 2022 | $787,362 | +72.7% | 77,344 | 0.0% | 0.47% | +79.6% |
| Q3 2022 | $456,000 | – | 77,344 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 970,000 | $8,487,500 | 5.75% |
| VR Adviser, LLC | 2,972,869 | $26,012,604 | 4.16% |
| Vivo Capital, LLC | 6,657,992 | $58,257,430 | 4.02% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,561,835 | $48,666,056 | 2.60% |
| Fairmount Funds Management LLC | 2,040,000 | $17,850,000 | 2.52% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $6,249,994 | 1.96% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 599,668 | $5,247,095 | 1.62% |
| Orbimed Advisors | 7,619,135 | $66,667,431 | 1.21% |
| CROSSPOINT FINANCIAL, LLC | 12,054 | $105,473 | 1.07% |
| HighVista Strategies LLC | 179,670 | $1,572,113 | 0.72% |